Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation

Br J Haematol. 2019 Nov;187(3):e64-e68. doi: 10.1111/bjh.16189. Epub 2019 Sep 5.

Authors

Razan Mohty¹, Eolia Brissot^{1

2}, Giorgia Battipaglia¹, Annalisa Ruggeri¹, Rémy Dulery¹, Agnès Bonnin¹, Clémence Médiavilla¹, Simona Sestili¹, Ramdane Belhocine¹, Anne Vekhoff¹, Tounes Ledraa¹, Camelia Simona Lapusan¹, Rosa Adaeva¹, Françoise Isnard¹, Olivier Legrand¹, Mohamad Mohty^{1

2}, Florent Malard^{1

2}

Affiliations

¹ Service d'Hématologie Clinique et de Thérapie cellulaire, APHP, Hôpital Saint Antoine, Paris, France.
² Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.

PMID: 31487392
DOI: 10.1111/bjh.16189

No abstract available

Keywords: haploidentical stem cell transplantation; infections; infectious complications; post-transplant cyclophosphamide.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Antilymphocyte Serum / therapeutic use
Cyclophosphamide / adverse effects
Cyclophosphamide / therapeutic use*
Female
Graft vs Host Disease / prevention & control
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods*
Humans
Immunosuppressive Agents / adverse effects
Infections / chemically induced
Infections / etiology*
Male
Middle Aged
Transplantation, Haploidentical / methods*

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Cyclophosphamide